share_log

Teladoc Health | 8-K: Teladoc Health Board of Directors Announces Leadership Transition

Teladoc Health | 8-K: Current report

Teladoc Health | 8-K:重大事件
SEC announcement ·  04/05 16:12
Moomoo AI 已提取核心訊息
On April 5, 2024, Teladoc Health, Inc. announced a leadership transition with the departure of Jason Gorevic as Chief Executive Officer and from the Board of Directors. Mala Murthy, the company's Chief Financial Officer since 2019, has been appointed as the acting CEO effective immediately. Murthy's extensive experience includes her role as CFO at American Express' Global Commercial Services and various leadership positions at PepsiCo. Alongside the executive change, Teladoc Health reaffirmed its financial outlook for Q1 and the full year of 2024, consistent with the previous earnings release on February 20, 2024. The financial results for Q1 2024 are preliminary and unaudited. The company has also initiated a search for a permanent CEO with the help of an executive search firm. In her new role, Murthy's base salary will increase to approximately $750,000 with a target bonus opportunity of 120% of her base salary, and she will receive an additional annual equity grant valued at around $1,100,000. Jason Gorevic will receive separation benefits as per his employment agreement.
On April 5, 2024, Teladoc Health, Inc. announced a leadership transition with the departure of Jason Gorevic as Chief Executive Officer and from the Board of Directors. Mala Murthy, the company's Chief Financial Officer since 2019, has been appointed as the acting CEO effective immediately. Murthy's extensive experience includes her role as CFO at American Express' Global Commercial Services and various leadership positions at PepsiCo. Alongside the executive change, Teladoc Health reaffirmed its financial outlook for Q1 and the full year of 2024, consistent with the previous earnings release on February 20, 2024. The financial results for Q1 2024 are preliminary and unaudited. The company has also initiated a search for a permanent CEO with the help of an executive search firm. In her new role, Murthy's base salary will increase to approximately $750,000 with a target bonus opportunity of 120% of her base salary, and she will receive an additional annual equity grant valued at around $1,100,000. Jason Gorevic will receive separation benefits as per his employment agreement.
2024 年 4 月 5 日,Teladoc Health, Inc. 宣佈領導層更替,傑森·戈雷維奇離任首席執行官並退出董事會。自2019年起擔任公司首席財務官的馬拉·穆爾西被任命爲代理首席執行官,立即生效。Murthy的豐富經驗包括她在美國運通全球商業服務擔任首席財務官以及在百事可樂擔任過各種領導職務。除了高管變動外,Teladoc Health還重申了其第一季度和2024年全年的財務前景,這與2024年2月20日發佈的業績一致。2024年第一季度的財務業績是初步的,未經審計。該公司還在一家獵頭公司的幫助下開始尋找常任首席執行官。在新職位上,Murthy的基本工資將增加到約75萬美元,目標獎金機會爲其基本工資的120%,並且她將獲得價值約1,100,000美元的額外年度股權補助。傑森·戈雷維奇將根據其僱傭協議獲得離職補助金。
2024 年 4 月 5 日,Teladoc Health, Inc. 宣佈領導層更替,傑森·戈雷維奇離任首席執行官並退出董事會。自2019年起擔任公司首席財務官的馬拉·穆爾西被任命爲代理首席執行官,立即生效。Murthy的豐富經驗包括她在美國運通全球商業服務擔任首席財務官以及在百事可樂擔任過各種領導職務。除了高管變動外,Teladoc Health還重申了其第一季度和2024年全年的財務前景,這與2024年2月20日發佈的業績一致。2024年第一季度的財務業績是初步的,未經審計。該公司還在一家獵頭公司的幫助下開始尋找常任首席執行官。在新職位上,Murthy的基本工資將增加到約75萬美元,目標獎金機會爲其基本工資的120%,並且她將獲得價值約1,100,000美元的額外年度股權補助。傑森·戈雷維奇將根據其僱傭協議獲得離職補助金。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息